Monika Mis

Monika Mis is an accomplished scientist with extensive experience in immunotherapy and therapeutic antibody development. Currently serving as Scientist 3 at Genentech since January 2021, Monika has engineered primary T-cells, initiated cross-functional collaborations, and expanded research projects to enhance T-cell engager activity in solid tumors. Prior to this role, Monika worked at MEDGENOME from 2019 to 2020, where collaboration and experimental design were central to deriving novel therapeutic antibodies. Monika's academic journey includes a Ph.D. in Pharmaceutical Sciences from the University of Toronto, where significant contributions were made to cancer research through CRISPR-Cas9 techniques, along with experience as a teaching assistant. Monika's educational background also includes a Bachelor's Degree in Biochemistry from York University.